Onconic Therapeutics Inc (476060)

Currency in KRW
25,300.00
-750.00(-2.88%)
Closed·
476060 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
476060 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25,250.0026,500.00
52 wk Range
12,550.0030,750.00
Key Statistics
Bid/Ask
25,300.00 / 25,400.00
Prev. Close
26,050
Open
26,350
Day's Range
25,250-26,500
52 wk Range
12,550-30,750
Volume
167.93K
Average Volume (3m)
419.8K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
476060 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Onconic Therapeutics Inc Company Profile

Onconic Therapeutics Inc. engages in the research and development of anti-cancer therapy in South Korea. It develops Zastaprazan (OCN-101), a potassium-competitive acid blocker, which is in phase 3 for the treatment of gastric acid related disease; and OCN-201 (JPI-547), an anticancer drug; JP-1366, a treatment for peptic ulcer; and drugs for DDR and immuno-oncology fields. JP-1366, a poly ADP-ribose polymerase inhibitor, which is in phase 1 for the treatment of pancreatic cancer. The company was founded in 2020 and is based in Seoul, South Korea.

Compare 476060 to Peers and Sector

Metrics to compare
476060
Peers
Sector
Relationship
P/E Ratio
−91.2x−9.0x−0.5x
PEG Ratio
-−0.110.00
Price/Book
4.9x2.7x2.6x
Price / LTM Sales
12.7x24.0x3.2x
Upside (Analyst Target)
-0.0%41.6%
Fair Value Upside
Unlock8.3%6.0%Unlock

Earnings

Latest Release
May 11, 2025
EPS / Forecast
173.38 / --
Revenue / Forecast
9.17B / --
EPS Revisions
Last 90 days

476060 Income Statement

People Also Watch

63,500
034020
-3.64%
57,800
272210
+1.23%
38,100
009830
-2.31%
1,394
033340
+0.14%
2,050
008970
+6.38%

FAQ

What Stock Exchange Does Onconic Therapeutics Trade On?

Onconic Therapeutics is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Onconic Therapeutics?

The stock symbol for Onconic Therapeutics is "476060."

What Is the Onconic Therapeutics Market Cap?

As of today, Onconic Therapeutics market cap is 288.21B.

What Is Onconic Therapeutics's Earnings Per Share (TTM)?

The Onconic Therapeutics EPS (TTM) is -291.84.

From a Technical Analysis Perspective, Is 476060 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Onconic Therapeutics Stock Split?

Onconic Therapeutics has split 0 times.

How Many Employees Does Onconic Therapeutics Have?

Onconic Therapeutics has 0 employees.

What is the current trading status of Onconic Therapeutics (476060)?

As of 28 Jul 2025, Onconic Therapeutics (476060) is trading at a price of 25,300.00, with a previous close of 26,050.00. The stock has fluctuated within a day range of 25,250.00 to 26,500.00, while its 52-week range spans from 12,550.00 to 30,750.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.